BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rubinstein YR, Robinson PN, Gahl WA, Avillach P, Baynam G, Cederroth H, Goodwin RM, Groft SC, Hansson MG, Harris NL, Huser V, Mascalzoni D, McMurry JA, Might M, Nellaker C, Mons B, Paltoo DN, Pevsner J, Posada M, Rockett-Frase AP, Roos M, Rubinstein TB, Taruscio D, van Enckevort E, Haendel MA. The case for open science: rare diseases. JAMIA Open 2020;3:472-86. [PMID: 33426479 DOI: 10.1093/jamiaopen/ooaa030] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Hendrickx K, Dooms M. Orphan Drugs, Compounded Medication and Pharmaceutical Commons. Front Pharmacol 2021;12:738458. [PMID: 34566662 DOI: 10.3389/fphar.2021.738458] [Reference Citation Analysis]
2 Hamilton DG, Fraser H, Fidler F, McDonald S, Rowhani-Farid A, Hong K, Page MJ. Rates and predictors of data and code sharing in the medical and health sciences: Protocol for a systematic review and individual participant data meta-analysis. F1000Res 2021;10:491. [PMID: 34631024 DOI: 10.12688/f1000research.53874.2] [Reference Citation Analysis]
3 Decherchi S, Pedrini E, Mordenti M, Cavalli A, Sangiorgi L. Opportunities and Challenges for Machine Learning in Rare Diseases. Front Med (Lausanne) 2021;8:747612. [PMID: 34676229 DOI: 10.3389/fmed.2021.747612] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tisdale A, Cutillo CM, Nathan R, Russo P, Laraway B, Haendel M, Nowak D, Hasche C, Chan CH, Griese E, Dawkins H, Shukla O, Pearce DA, Rutter JL, Pariser AR. The IDeaS initiative: pilot study to assess the impact of rare diseases on patients and healthcare systems. Orphanet J Rare Dis 2021;16:429. [PMID: 34674728 DOI: 10.1186/s13023-021-02061-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wen X, Yang Y, Klionsky DJ. Moments in autophagy and disease: Past and present. Mol Aspects Med 2021;:100966. [PMID: 33931245 DOI: 10.1016/j.mam.2021.100966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Groenen KHJ, Jacobsen A, Kersloot MG, Dos Santos Vieira B, van Enckevort E, Kaliyaperumal R, Arts DL, 't Hoen PAC, Cornet R, Roos M, Kool LS. The de novo FAIRification process of a registry for vascular anomalies. Orphanet J Rare Dis 2021;16:376. [PMID: 34481493 DOI: 10.1186/s13023-021-02004-y] [Reference Citation Analysis]
7 Taruscio D, Mantovani A. Multifactorial Rare Diseases: Can Uncertainty Analysis Bring Added Value to the Search for Risk Factors and Etiopathogenesis? Medicina (Kaunas) 2021;57:119. [PMID: 33525390 DOI: 10.3390/medicina57020119] [Reference Citation Analysis]